Themis Medicare reschedules November board meeting

Compliance View source PDF Explain this filing

THEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.5%Reaction day

₹94.15

prior close

₹100.81

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+6.0% vs market

Pharmaceuticals peers, median of 174sector+0.2%+7.3% vs sector

On the reaction day the stock moved 6.0 pts more than Nifty Microcap 250 and 7.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.2

15m

-0.6

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.5+1.4+6.0+0.2+7.3

Next day

+6.0+1.7+4.3+0.6+5.4

+6.0+3.9+2.1+1.6+4.4

+8.3pendingpending+2.3+5.9

+6.8pendingpending+2.2+4.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board meeting has moved from November 5, 2026 to November 14, 2026 to approve standalone and consolidated unaudited results for the quarter and half year ended September 30, 2026. The company cited unavoidable circumstances. The trading window remains closed for designated persons and their immediate relatives until 48 hours after publication of the results.

Likely market impact

The nine-day delay defers the results. Covered insiders cannot trade until 48 hours after publication; no financial figures were provided.